Home

Applied DNA Sciences, Inc. - Common Stock (APDN)

2.2600
+2.2069 (4156.12%)

Applied DNA Sciences is a biotechnology company that specializes in providing molecular solutions for supply chain security, product authenticity, and anti-counterfeiting measures

The company develops and employs proprietary DNA tagging technology to enable businesses to protect their products and verify their origins, enhancing transparency and trust in various industries, including pharmaceuticals, textiles, and consumer goods. Applied DNA Sciences also explores applications for its technology in fields such as biodefense and forensic science, making it a key player in the fight against counterfeit products and ensuring product integrity.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close0.0531
Open2.740
Bid2.010
Ask2.020
Day's Range1.950 - 2.755
52 Week Range0.0507 - 10.75
Volume646,893
Market Cap122.29M
PE Ratio (TTM)-0.4458
EPS (TTM)-5.1
Dividend & YieldN/A (N/A)
1 Month Average Volume3,930,685

News & Press Releases

What's going on in today's after hours sessionchartmill.com
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 14, 2025
Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · March 14, 2025
Which stocks are experiencing notable movement on Friday?chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · March 14, 2025
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
- Announces Exit of DNA Tagging and Security Products and Services Business Segment -
Via ACCESS Newswire · February 13, 2025
Earnings Scheduled For February 13, 2025benzinga.com
Via Benzinga · February 13, 2025
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
Investor Call and Webcast Scheduled for 4:30 P.M ET
Via ACCESS Newswire · February 12, 2025
Which stocks are gapping on Friday?chartmill.com
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Via Chartmill · March 14, 2025
What's going on in today's pre-market sessionchartmill.com
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · March 14, 2025
Top movers in Wednesday's sessionchartmill.com
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · March 12, 2025
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
- Signals Start of New Commercialization Phase for LineaRx Subsidiary -
Via ACCESSWIRE · January 10, 2025
Which stocks are experiencing notable movement on Wednesday?chartmill.com
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · March 12, 2025
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · March 12, 2025
Get insights into the top gainers and losers of Wednesday's pre-market session.chartmill.com
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · March 12, 2025
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQAPDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-50 reverse stock split of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on Friday, March 14, 2025, and Applied DNA common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market as of the commencement of market open that same day.
Via ACCESS Newswire · March 12, 2025
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQAPDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a Special Meeting of Stockholders (the "Special Meeting") to be held on Friday, February 14, 2025 at 11:00 a.m.
Via ACCESS Newswire · February 11, 2025
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQAPDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide with the release of its first quarter fiscal 2025 financial results.
Via ACCESSWIRE · January 8, 2025
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
- Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies -
Via ACCESSWIRE · December 18, 2024
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streakbenzinga.com
U.S. stock futures climbed on Wednesday as Wall Street awaits the Fed's final interest rate decision and its monetary policy forecasts for 2025.
Via Benzinga · December 18, 2024
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 18, 2024
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesdaybenzinga.com
Via Benzinga · December 18, 2024
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -
Via ACCESSWIRE · December 17, 2024
Earnings Scheduled For December 17, 2024benzinga.com
Via Benzinga · December 17, 2024
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
STONY BROOK, NY / ACCESSWIRE / December 16, 2024 / Applied DNA Sciences, Inc. (NASDAQAPDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and fiscal year 2024 financial results after the market close on Tuesday, December 17, 2024.
Via ACCESSWIRE · December 16, 2024
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecastbenzinga.com
Via Benzinga · October 30, 2024
S&P 500 Edges Lower; US Crude Oil Inventories Fallbenzinga.com
Via Benzinga · October 30, 2024